CSI-Sydney: New technologies to treat chronic sinus infection

CSI-悉尼：治疗慢性鼻窦感染的新技术

• 批准号: nhmrc : 1076217
• 负责人: A/Pr Cynthia Whitchurch
• 金额: $ 27.49万
• 依托单位: Australian National University
• 依托单位国家: 澳大利亚
• 项目类别: Development Grants
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/csi-sydney-new-sinus-infection/455723
• 关键词: CSI; Sydney; New; technologies; treat

Chronic sinus infection (CSI) is prevalent and results in severe discomfort and pain for many Australians; yet amazingly, has no specific cure or effective treatment. Our multi-disciplinary research team and an Australian health and medical research company, (AFT Pharmaceuticals) have partnered to develop a novel device that specifically targets the sinuses and a formulation capable for simultaneously removing mucus, dispersing biofilms and killing bacteria in the nasal cavities.

慢性鼻窦感染（CSI）是普遍存在的，并导致严重的不适和疼痛，许多澳大利亚人;但令人惊讶的是，没有具体的治愈或有效的治疗。我们的多学科研究团队和一家澳大利亚健康和医学研究公司（AFT Pharmaceuticals）合作开发了一种专门针对鼻窦的新型设备，以及一种能够同时去除粘液、分散生物膜和杀死鼻腔中细菌的配方。